WHAT AND WHERE IS HEAVEN?

Does heaven exist? With well over 100,000 plus recorded and described spiritual experiences collected over 15 years, to base the answer on, science can now categorically say yes. Furthermore, you can see the evidence for free on the website allaboutheaven.org.

Available on Amazon
https://www.amazon.com/dp/B086J9VKZD
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)

VISIONS AND HALLUCINATIONS

This book, which covers Visions and hallucinations, explains what causes them and summarises how many hallucinations have been caused by each event or activity. It also provides specific help with questions people have asked us, such as ‘Is my medication giving me hallucinations?’.

Available on Amazon
https://www.amazon.com/dp/B088GP64MW 
also on all local Amazon sites, just change .com for the local version (.co.uk, .jp, .nl, .de, .fr etc.)


Observations placeholder

Efficacy of a kaurenic acid extracted from the Venezuelan plant Wedelia trilobata (Asteracea) against Leishmania (Viannia) braziliensis

Identifier

019421

Type of Spiritual Experience

Background

A description of the experience

Biomedica. 2006 Oct;26 Suppl 1:180-7.

[Efficacy of a kaurenic acid extracted from the Venezuelan plant Wedelia trilobata (Asteracea) against Leishmania (Viannia) braziliensis].

[Article in Spanish]

Brito S1, Crescente O, Fernández A, Coronado A, Rodriguez N.

  • 1Universidad de Oriente, Cumaná, Estado Sucre, Venezuela.

Abstract

INTRODUCTION:

Leishmaniasis is a global public health problem without adequate treatment options, hence requiring research on new drug development.

OBJECTIVE:

Our main objective was the evaluation of a kaurenic acid (ent-kaur-16-in-19-oico), isolated from the Venezuelan plant Wedelia trilobata (Asteracea), on Leishmania (V) braziliensis both in vivo and in vitro.

MATERIALS AND METHODS:

The in vitro assay was performed using axenic amastigotes and promastigotes as well as infected and uninfected macrophages. Parasites and macrophages were treated with concentrations of the compound varying between 10 and 250 microg/ml. The effect of the compound on cellular viability was evaluated by counting dead and living cells in a hemocytometer and by the colorimetric method using MTT (Methylthiazoletetrazolium). For the in vivo assay, Balb/c mice were infected subcutaneously with 1 x 10(6) promastigotes of L. (V.) braziliensis and afterwards treated with a daily dose of 30 mg/kg in 100 microl of kaurenic acid administered by intraperitoneal injection for one week.

RESULTS:

The compound had a lethal effect on axenic amastigotes and promastigotes with DL50 of 0.25 and 0.78 microg/ml, respectively, in 24 hours. Low toxicity was observed for J774-G8 macrophages with a DL50 of 25 microg/ml and high viability (70-92%), while a moderate viability was observed for infected macrophages (37-81%), with concentrations of 25 microg/ml or less. Additionally, a 70% reduction was observed in the size of the skin lesions in Balb/c mice with no evident toxic effect.

CONCLUSION:

The results indicate that this compound has a potent leishmanicidal effect on L. (V.) braziliensis.

PMID:

17361853

The source of the experience

PubMed

Concepts, symbols and science items

Concepts

Symbols

Science Items

Activities and commonsteps

Activities

Overloads

Leishmaniasis

Suppressions

Wedelia

Commonsteps

References